(Overweight)
357,229 results
  • Myo-inositol to prevent gestational diabetes: "What do conflicting trials tell clinicians?". [Editorial]
    Am J Obstet Gynecol. 2026 Oct 12. [Online ahead of print]Lecis S, D'Anna R, … Facchinetti FAJ
  • CONCLUSIONS: The recent meta-analysis provided a signal of benefit of myo-inositol for prevention of gestational diabetes mellitus. This clinical perspective identifies and discusses clinical and methodological differences that may have contributed to the variability in results across trials. However, the available evidence does not establish the optimal target population, supplementation protocol, or timing of treatment initiation. Adequately powered randomized trials focusing on short- and long-term neonatal outcomes are needed to better define the efficacy and safety of myo-inositol for the prevention of gestational diabetes mellitus.
  • Digital Health Interventions for Weight Management in Older Adults with Overweight or Obesity: A Scoping Review. [Review]
    Diabetes Metab Syndr Obes. 2026; 19:641439.Li L, Ren K, … Zhao QDM
  • CONCLUSIONS: DHIs for weight management in older adults with overweight or obesity are characterized by diverse technological carriers, multifaceted intervention content, and multidimensional outcomes. Future efforts should focus on participatory age-friendly design involving older adults, development of a core outcome set (COS), and integration of emerging technologies to improve the precision, sustainability, and scalability of interventions.
  • Beyond metabolic comorbidity: metabolic health stratification reveals BMI-ART associations in tubal factor infertility. [Journal Article]
    J Ovarian Res. 2026 Aug 28; 19(1).Wan X, Yu M, … Tan JJO
  • CONCLUSIONS: The impact of BMI on ART outcomes is independent of metabolic health status. Overweight/obesity exerts consistent detrimental effects on embryological outcomes, while metabolic comorbidities do not modify these associations. Metabolic health stratification suggests that adiposity per se, rather than its associated metabolic abnormalities, may be the primary factor associated with BMI-ART outcomes in tubal factor infertility, although the lack of significant interaction does not exclude metabolic modification.